...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Resverlogix Invites Collaborations for use of Apabetalone in Trials and Studies to Combat the Spread of COVID-19 Based on New Research

The problem is they never PR'd that they were presenting,... justifies not PR'ing they are not presenting.

Share
New Message
Please login to post a reply